Heterogeneous Postprandial Lipoprotein Responses in the Metabolic Syndrome, and Response to Fenofibrate Therapy

By Rosenson Robert   Helenowski Irene   Tangney Christine  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 439-447

Springer Publishing Company

Access to resources Recommend Favorite

Fenofibrate: A Review of its Use in Primary Dyslipidaemia, the Metabolic Syndrome and Type 2 Diabetes Mellitus

By Keating Gillian M.   Croom Katherine F.  

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 121-153

Adis International

Access to resources Recommend Favorite

Fenofibrate: DRESS syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Coadministration of Fenofibrate and Ezetimibe Compared with Each as Monotherapy in Patients with Type IIb Dyslipidemia and Features of the Metabolic Syndrome: A Prospective, Randomized, Double-Blind, Three-Parallel Arm, Multicenter, Comparative Study

By Ansquer Jean-Claude  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 2, 2009-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Metabolism of fenofibrate in beagle dogs: New metabolites identified and metabolic pathways revealed

By Yang Julin   Luo Wenxia   Chen Li   Dai Renke   Liu Aiming  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 6, 2013-06 ,pp. : 414-420

Govi-Verlag

Access to resources Recommend Favorite